Hyperprogressive Disease in Patients With Advanced Non–Small Cell Lung Cancer Treated With PD-1/PD-L1 Inhibitors or With Single-Agent Chemotherapy
Roberto Ferrara(Vita-Salute San Raffaele University), Caroline Caramella(Institut Gustave Roussy)
Cited by 731
Related Papers
Cancer of the pancreas: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up
|Annals of Oncology|2015|1.3k
Current standards and new innovative approaches for treatment of pancreatic cancer
|European Journal of Cancer|2016|186